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Research
AbstrAct
Objective With survival following paediatric cardiac 
surgery improving, the attention of quality assurance 
and improvement initiatives is shifting to long-term 
outcomes and early surgical morbidities. We wanted to 
involve family representatives and a range of clinicians 
in selecting the morbidities to be measured in a major 
UK study.
Setting Paediatric cardiac surgery services in the UK.
Participants We convened a panel comprising family 
representatives, paediatricians from referring centres, 
and surgeons and other clinicians from surgical centres.
Primary and secondary outcome measures Using 
the nominal group technique augmented by a 
robust voting process to identify group preferences, 
suggestions for candidate morbidities were elicited, 
discussed, ranked and then shortlisted. The shortlist 
was passed to a clinical group that provided a view on 
the feasibility of monitoring each shortlisted morbidity 
in routine practice. The panel then met again to 
select a prioritised list of morbidities for further study, 
with the list finalised by the clinical group and chief 
investigators.
Results At the first panel meeting, 66 initial suggestions 
were made, with this reduced to a shortlist of 24 after 
two rounds of discussion, consolidation and voting. At the 
second meeting, this shortlist was reduced to 10 candidate 
morbidities. Two were dropped on grounds of feasibility 
and replaced by another the panel considered important. 
The final list of nine morbidities included indicators of 
organ damage, acute events and feeding problems. Family 
representatives and clinicians from outside tertiary centres 
brought some issues to greater prominence than if the 
panel had consisted solely of tertiary clinicians or study 
investigators.
Conclusion The inclusion of patient and family 
perspectives in identifying metrics for use in monitoring a 
specialised clinical service is challenging but feasible and 
can broaden notions of quality and how to measure it.
InTroducTIon
Early mortality following paediatric cardiac 
surgery, defined as death within 30 days of 
surgery or death prior to discharge home, has 
been the focus of many research studies,1–10 
audit initiatives6 11–14 and, particularly in the 
UK, of public scrutiny1 15–20 over recent decades. 
However, with early mortality having fallen to 
2%–3%,21 attention has shifted to longer term 
outcomes and to broadening the assessment of 
early outcomes to include early morbidities.
Strengths and limitations of this study
 ► The nominal group technique, augmented by a robust 
secret voting process, allowed us to incorporate the 
perspectives of family representatives and clinicians 
from different professional groups in selecting early 
surgical morbidities they felt important to monitor in 
routine practice.
 ► The robust voting process used identified group 
preferences from the preferences expressed by 
individual panellists and identified where there was 
a lack of consensus, guiding further discussion.
 ► One limitation of the approach adopted was that it 
relied on firm and expert chairing.
 ► There was some unresolved tension between 
selecting morbidities clearly attributable to the 
surgical act and morbidities that are important 
to families but can be considered to ‘come with 
the territory’ of congenital heart disease and its 
management.
 ► Relying on a face-to-face approach necessarily 
limited the size of the panel, and we cannot claim 
that  the priorities and preferences expressed are 
representative of the respective professional groups 
and of families in general.
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Reporting of early morbidities associated with paedi-
atric cardiac surgery has been driven largely by the data 
available within the databases of professional societies12 or 
those available within data sets curated by individual clin-
ical teams.22 Quality assurance initiatives rooted in such 
data sets benefit greatly from considerable effort, often over 
many years, to agree on the definitions of the outcomes 
collected and design data collection processes. However, 
it is inevitable that the data sets agreed on, constructed 
and curated by clinicians (as individuals or via professional 
societies) focus largely on outcomes considered important 
from the perspective of that clinician or professional group. 
Research in other specialties has shown that patients and 
carers can have quite different perceptions to clinicians on 
what outcomes are important to monitor as part of service 
evaluation.23
We report here on a process used to select early morbid-
ities as part of a study to identify and then measure the 
incidence and impact of important early morbidities among 
paediatric cardiac surgery patients (National Institute of 
Health Research Health Services and Delivery Research 
programme (NIHR HS&DR) 12/5005/06).24 A key aim 
of our work was to incorporate a broad set of perspectives, 
including those from family representatives and profes-
sionals from different sectors, on what early morbidities 
were important to monitor in routine practice.
MeThods
overview
Figure 1 gives an overview of the role of our selection 
process within the wider study. A panel of clinicians and 
patient representatives met twice to shortlist and then 
Figure 1 The role of the selection panel within our wider study to identify and measure the incidence and impact of important 
morbidities following paediatric cardiac surgery.
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to select early morbidities, the incidence and impact of 
which they considered important to measure. As shown 
in figure 1, our selection process was linked to a parallel 
process of defining potential morbidities. The shortlist of 
morbidities produced after the first meeting of the selec-
tion panel was considered by a separate group composed 
entirely of clinicians. This definition panel provided a view 
on the feasibility of defining, measuring and routinely 
monitoring each shortlisted morbidity, which informed 
the second selection meeting.
composition of the selection panel
In forming the panel, we aimed to include clinicians from 
surgical centres, referring hospitals and primary care, 
as well as family representatives. We wanted a panel of 
enough people to provide a range of perspectives while 
being manageable.
The panel comprised 15 people: three family represen-
tatives, three paediatric cardiac surgeons, two paediatric 
intensive care doctors, two paediatric cardiologists, two 
paediatricians, a paediatric intensive care nurse, a clin-
ical nurse specialist and a clinical psychologist with 
experience of working with children with congenital 
heart disease and their families. The panel was chaired 
by a cardiothoracic surgeon with extensive experience of 
chairing multidisciplinary panels. Two of the three family 
representatives were nominated by the Children’s Heart 
Federation, a parent-led charity and umbrella organisa-
tion of congenital heart disease  charities and voluntary 
organisations. The third had facilitated one of the focus 
groups that fed into the selection process. We tried, but 
did not manage, to recruit a general practitioner to the 
panel.
With the permission of panel members, both selec-
tion panel meetings were recorded and professionally 
transcribed. Each selection panel meeting also had a 
predetermined seating plan to ensure that people from 
similar specialties were not grouped together.
selection panel meeting 1: shortlisting
The aim of the first meeting was to identify a shortlist of 
15–20 candidate morbidities that would then be consid-
ered by the definitions group. Prior to the meeting, the 
panel was supplied with an extensive list of candidate 
morbidities identified through the following:
 ► an ongoing systematic review conducted as part of 
our wider programme of research;
 ► three facilitated focus groups held in different UK 
cities with parents recruited by the Children’s Heart 
Federation; and
 ► an online forum for patients and families hosted on 
the website of the Children’s Heart Federation.
The focus groups and literature review will be the 
subject of other publications. The panel was also sent 
an abridged version of the study protocol, a description 
of the role of the selection panel and an agenda. Each 
panellist was asked to identify among or beyond this list of 
candidate morbidities those they judged most important 
to monitor routinely according to a deliberately broad 
working definition of a surgical morbidity as:
Any health or emotional problem that arose as a result of the 
fact of surgery (whether directly caused by surgery/postoperative 
care or not).
For the first meeting, panellists were requested not to 
censor their suggestions on grounds of the perceived diffi-
culty of definition or measurement, and it was stressed 
that another group would be making these judgements.
We used the nominal group technique25 26 augmented 
by a robust voting process to determine group rankings 
of morbidities. The nominal group technique is designed 
to reduce the influence of perceived power differentials 
and of dominant personalities on group decision making 
while retaining the benefit of discussion absent from 
other systematic approaches to group decision making 
such as Delphi.27 28 We inferred group preferences from 
individual rankings using a method developed by Utley et 
al,29 which is briefly described in  the online supplemen-
tary appendix 1.
structure of the first panel meeting
Each panellist was given the opportunity to speak unin-
terrupted for 2 min on the morbidities they considered 
important. Each suggestion was entered onto a spread-
sheet, which was projected in the meeting room to ensure 
accurate transcription. The panel was then given the 
opportunity to add to this initial list if they thought some-
thing important had been missed.
The Chair led a process of identifying suggestions that 
fell outside the working definition above, duplication 
among suggestions and merging of closely related sugges-
tions. There was then a secret ballot in which panellists 
were asked individually to rank the resulting list of candi-
date suggestions in order of descending importance. The 
voting process and the method for generating group 
preferences from individual ranking data are described 
further in the online supplementary appendix 1.
During a scheduled break, the group preferences 
were calculated from the individual rankings by two of 
the authors (CP, MU), who did not have a vote on which 
morbidities to measure. After the break, the group pref-
erences were fed back to the panel. The Chair then led a 
second round of discussion, focusing on the group pref-
erences and giving panellists the opportunity to argue for 
specific morbidities being given greater importance, and 
for the group to further consolidate the list of morbidi-
ties.
There was a second round of secret ranking followed by 
feedback of group preferences prior to a consensus being 
sought as to the prioritised shortlist of 15–20 morbidi-
ties to be passed to the separate definitions panel for an 
assessment on the feasibility of defining, measuring and 
monitoring each in routine practice.
causal mapping
Following the first selection group meeting, it was 
decided that it might be useful for non-clinical members 
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of the panel to have an accessible summary of any causal 
relationships among candidate morbidities so that, 
when choosing the best set of morbidities to monitor, 
any overlap or redundancy among candidates could 
be accounted for. To this end, a set of causal mapping 
exercises was conducted by one of the facilitative team 
(MU) separately with two of the panellists (IM and HJ). 
In each exercise, cards representing shortlisted morbid-
ities were placed on a large sheet of paper and arranged 
left to right with lines drawn to indicate potential causal 
relationships. Photographs were taken of these causal 
maps, which were then converted to diagrams.
selection panel meeting 2: incorporating feasibility and 
overlap
Prior to the second meeting, panellists were provided 
with a pack of materials containing:
 ► a summary of any estimates of incidence and impact 
of candidate morbidities from the systematic review;
 ► the judgement of the definition panel on the 
feasibility of defining, measuring and monitoring 
routinely each candidate morbidity; 
 ► a summary of potential long-term impacts of each 
candidate morbidity from the definition panel 
 ► a summary of the parent and family focus groups 
and the online forum; 
 ► the diagrams generated through the causal mapping 
exercise;
 ► minutes from the first meeting;
 ► a statement of the purpose of the second meeting 
and its agenda.
At the beginning of the second meeting, the panel was 
given a brief reminder of the scope of the overall project, 
the remit of the selection panel and the timescales we 
were working to.
The panel was tasked with narrowing the list of short-
listed candidates to a selection of 6–10, the incidence 
and impact of which would be measured in five centres 
over 18 months.30 It was explained that the upper limit 
of 10 morbidities was due to the sample size required 
for measuring the impact of distinct morbidities. It was 
explained that we could measure just the incidence of 
other morbidities if possible from routine data.
Panellists were also alerted to the (then) recently 
launched NHS England consultation on the future of 
Children’s Heart Services in England, which highlighted 
the possibility of future national audit of surgical morbid-
ities.
Panellists were asked to consider the following:
 ► Feasibility of measurement, including timescales. Given 
our plans to measure the impact of morbidities, 
the project team stressed that selected morbidities 
needed to be identifiable in a timely manner.
 ► Overlap and redundancy among selected morbidities. 
The project team made the point that selecting 
morbidities that almost always occur with other 
selected morbidities would pose problems in terms 
of measuring their individual impact. It highlighted 
that the length of stay measures are particularly 
problematic in this respect.
 ► Incidence. Selected morbidities needed to have an 
incidence of at least 1.5%–2% for us to measure 
their impact over 18 months due to sample size 
considerations.
A summary of the judgements of the definition panel 
was presented to the panel, consisting of an array showing 
the shortlisted candidates placed vertically based on the 
group ranking of importance from meeting 1  and hori-
zontally in terms of the feasibility of monitoring that 
morbidity.
The panel was then asked in a secret ballot to nominate 
morbidities for exclusion without further discussion and 
others for inclusion without further discussion. The panel 
discussed the remaining morbidities as a group.
After the panel meeting, a written summary of the 
discussion was circulated and an online poll conducted to 
obtain the group ranking of importance among the short-
listed candidate morbidities. The poll was conducted to 
elicit the views of panellists who weren’t able to attend 
and to identify replacement morbidities if any of those 
selected were judged to be infeasible to monitor in 
routine practice. We used the online voting tool at www. 
crankit. io, which uses the same algorithm for robustly 
inferring group preferences from individual preference 
data that were used in the selection meetings and that are 
outlined in the online supplementary appendix 1.
Final review of selected morbidities by definition panel and 
chief investigators
The selected morbidities were then reviewed by the defi-
nition panel, which could veto inclusion of a selected 
morbidity if, after careful consideration and discussion 
with the chief investigators (VT, KLB), it was deemed 
infeasible to define and monitor in routine practice.
Governance
The study ‘Selection, definition and evaluation of 
important early morbidities associated with paediatric 
cardiac surgery’ received a Favourable Opinion from the 
National Research Ethics Service London City Road & 
Hampstead Research Ethics Committee on 8 November 
2013 (REC reference 13/LO/1442).
resulTs
The panel convened is given in the online supplemen-
tary appendix 2. Of the 15 panellists, 3 could not attend 
the first meeting and 6 could not attend the second. An 
overview of the results of the selection process is given in 
figure 2.
First panel meeting
At the first meeting, 66 morbidity terms were suggested 
during the round of 2 min contributions from each 
panellist (see online supplementary appendix 3). In 
the discussion that followed, seven terms were removed 
as being irrelevant to our study, related to impacts of 
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postsurgical morbidity that would either be measured 
as part of our empirical study or were too long-term in 
nature to be captured within our study, or redundant 
given other terms suggested.
Of the remaining 59, 7 were accepted as candidate 
morbidities as they were and a further 5 were simply rela-
belled. The remaining 47 terms were mapped onto 16 
groups of 2–8 terms, with each group considered to relate 
to a sufficiently similar phenomenon for them to be a single 
candidate morbidity. The members of the panel confirmed 
that it wanted the term ‘ECMO/mechanical support’ to 
feature on its own, as well as being an indicator of a ‘major 
adverse event’. A new term (‘liver injury’) was added as a 
candidate at this stage with the agreement of the panel. 
This gave 29 candidate morbidities.
These candidate morbidities and the group ranking of 
importance among them in the first round of voting are 
shown in table 1. It is worth noting that, in this first round 
of voting, the group ranked ‘new global permanent neuro-
logical impairment’ as the most important morbidity. 
After that there was a group of 22 candidate morbidities 
that could only be separated by applying tie-breaks, with 
the other six candidate morbidities (including ‘necro-
tising enterocolitis’) ranked as less important.
In the discussion that followed the first round of voting, 
the panel merged the two items describing neurological 
impairment, and individual panellists expressed surprise 
at the low ranking of ‘necrotising enterocolitis’ and 
‘vascular thrombosis’, leading to a discussion of these 
particular morbidities and their impact.
The results of the second round of voting are shown in 
table 2. While the panel’s view of the top three morbid-
ities (including the merged item of ‘new permanent 
neurological impairment’ (global or focal)) was clear, 
there was a large group of 21 candidates that could only 
be separated by applying tie-breaks. This group included 
‘necrotising enterocolitis’ and ‘vascular thrombosis’. 
Given the lack of unambiguous group preference among 
these 21, the panel decided to request that the separate 
definition panel consider the 24 candidate morbidities 
given in bold in table 2, with the remainder discarded.
second panel meeting
The initial assessment of the definition panel as to the 
feasibility of defining and monitoring each candidate 
morbidity still in contention after the first selection panel 
meeting is shown to the right of figure 2, and as presented 
to the panel in the online supplementary appendix 4.
Eleven candidate morbidities were considered 
straightforward to define and monitor in routine prac-
tice: ‘unplanned reoperation/reintervention’, ‘length 
of ICU stay’, ‘major adverse event (eg, cardiac arrest, 
ECMO, serious untoward incident)', ‘ECMO/mechanical 
support’, ‘necrotising enterocolitis’, ‘prolonged hospital 
Figure 2 Overview of results of selection process.
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length of stay’, ‘acute kidney injury’, ‘prolonged pleural 
effusion’, ‘vascular thrombosis’, ‘surgical bleeding’ and 
‘complete heart block’.
Six candidate morbidities were considered less 
straightforward: ‘new permanent neurological 
impairment (global or focal)', ‘problems feeding’, 
‘hospital acquired infection’, ‘poor communication 
between clinical team and family’, ‘complications 
during surgery’ and ‘phrenic nerve injury’.
Table 1 Results of the first ranking exercise
Morbidities
Rank before 
tie-breaks
Rank after 
tie-breaks
New global permanent 
neurological impairment 1 1
New impaired cognitive function 
more than a month after surgery 2 2
Unplanned reoperation/
reintervention 2 3
Developmental delay 2 4
Major adverse event 2 5
Problems feeding (graded) 2 6
Mental health consequences 2 7
Length of ICU stay 2 8
New focal permanent 
neurological impairment 2 9
Low cardiac output (categorised) 2 10
Poor communication between 
clinical team and family 2 11
ECMO/mechanical support 2 12
Acute kidney injury (graded) 2 13
Prolonged pleural effusion 2 14
Complications during surgery 2 15
Hospital acquired infection 
(graded/categorised) 2 15
Prolonged hospital length of stay 2 17
Complete heart block 
(categorised) 2 18
Surgical bleeding (graded) 2 19
Questionable clinical team 
decision & diagnosis 2 20
Level of support from hospital 
available at home 2 21
Recurrent laryngeal nerve palsy 2 21
Phrenic nerve injury 2 23
Necrotising enterocolitis 24 24
Vascular thrombosis (graded) 25 25
JET 26 26
Elevated pulmonary vascular 
resistance 27 27
Liver injury (graded) 27 27
Sensory neural deafness 27 27
Note that for some suggested morbidities, the panel indicated 
that a grading or categorisation scheme would be required if that 
morbidity were to be used. The definition of an appropriate grading 
or categorisation scheme was left to the separate definitions panel, 
with only those morbidities selected subject to the full definition 
process.
ICU, intensive care unit.  ECMO, extracorporeal membrane 
oxygenation, JET,  junctional ectopic tachycardia.
Table 2 Results of the second round of ranking
Morbidities
Rank before 
tie-breaks
Rank after 
tie-breaks
New permanent neurological 
impairment (global or focal) 1 1
New impaired cognitive 
function more than a month 
after surgery 2 2
Unplanned reoperation/
reintervention (categorisation) 3 3
Length of ICU stay 4 4
Major adverse event 4 5
Problems feeding (graded) 4 6
Developmental delay 4 7
ECMO/mechanical support 4 8
Low cardiac output 
(categorised) 4 8
Mental health consequences 4 10
Necrotising enterocolitis 4 11
Hospital acquired infection 
(graded/categorised) 4 12
Prolonged hospital length of 
stay 4 13
Acute kidney injury (graded) 4 14
Prolonged pleural effusion 4 15
Poor communication between 
clinical team and family 4 16
Recurrent laryngeal nerve palsy 4 17
Vascular thrombosis (graded) 4 18
Surgical bleeding (graded) 4 19
Complications during surgery 4 20
Complete heart block 
(categorised) 4 21
Questionable clinical team 
decision & diagnosis 4 22
Phrenic nerve injury 4 23
Level of support at home 4 24
JET 25 25
Sensory neural deafness 26 26
Elevated pulmonary vascular 
resistance 27 27
Liver injury (graded) 27 27
The morbidities passed to the definition panel for consideration are 
shown in bold.
ICU, intensive care unit.
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The remaining seven candidate morbidities were 
deemed difficult to define and monitor in routine prac-
tice: ‘new impaired cognitive function more than a 
month after surgery’, ‘developmental delay’, ‘low cardiac 
output’, ‘mental health consequences’, ‘recurrent laryn-
geal nerve palsy’, ‘questionable clinical team decision & 
diagnosis’ and ‘level of support at home’.
The output from the causal mapping exercises given 
in the online supplementary appendix 5 highlighted 
how ‘mental health consequences’ could be a result of 
several other candidate morbidities, how the majority of 
candidate morbidities could result in prolonged stay in 
intensive care or hospital, and how ‘low cardiac output’ 
could become manifest in several of the other candidate 
morbidities.
Based on these assessments and the selection panel’s 
own previous assessment of the importance of these 
morbidities, it was agreed that the following candidate 
morbidities would be selected without further discus-
sion: ‘new permanent neurological impairment (global 
or focal)', ‘unplanned reoperation/reintervention’, 
‘problems feeding’, ‘acute kidney injury’ and ‘poor 
communication between clinical team and family’.
The following candidate morbidities were discarded 
at this point without further discussion: ‘mental health 
consequences’, ‘prolonged hospital stay’, ‘questionable 
clinical team decision & diagnosis’ and ‘level of support 
at home’.
The remaining 15 candidate morbidities were then 
discussed, with the panel reminded of the need to select 
at most 5 from these 15. Group decisions were made 
to select ‘ECMO’, ‘major adverse event’, ‘necrotising 
enterocolitis’, ‘hospital acquired infection’ and ‘recur-
rent laryngeal nerve palsy’. Note that the group accepted 
that ‘major adverse event’ should not include ECMO as 
this had been selected as a distinct morbidity.
Group decisions were made to discard at this stage ‘new 
impaired cognitive function more than  one month after 
surgery’, ‘developmental delay’, ‘low cardiac output’, 
‘prolonged pleural effusion’, ‘vascular thrombosis’, 
‘surgical bleeding’, ‘complications during surgery’, 
‘phrenic nerve injury’ and ‘length of ICU stay’.
The online poll conducted after the second panel 
meeting identified ‘recurrent laryngeal nerve palsy’, 
‘phrenic nerve injury’, ‘complete heart block’ and 
‘prolonged pleural effusion’ as potential substitute 
morbidities in the event of the definition panel vetoing 
any of the selected morbidities in routine practice.
Final rulings of definitions panel and chief investigators
Of the 10 morbidities selected by the panel, 2 (‘poor 
communication between clinical team and family’ and 
‘recurrent laryngeal nerve palsy’) were removed from 
the final list by the definitions panel following input 
from and consultation with the chief investigators (VT 
and KLB) and other members of the project manage-
ment team. In each case this was done on the grounds 
that the morbidity concerned would be too problem-
atic to measure in routine practice. The morbidity 
‘prolonged pleural effusion’ was added to the final list 
of morbidities as a substitute. Feeding problems due to 
symptomatic recurrent laryngeal nerve palsy were then 
included under ‘problems feeding’. The definition 
panel and the project team decided to monitor the inci-
dence of phrenic nerve injury and complete heart block 
by using routinely collected cardiac audit data. These 
changes were shared with the selection panel.
The final nine morbidities chosen for inclusion in the 
study, using the revised labels used in working up final 
definitions, are given in box 1. A detailed description of 
the definition process and the final definitions used is 
available in a separate paper.31
Alongside these nine, the study team committed to 
measuring poor communication between the clinical 
team and the family among the 800+ patients antici-
pated to enter the matched cohort phase of our study, 
and to conducting secondary analyses to identify the 
impact of longer stays in intensive care above and 
beyond the impact of the selected morbidities.
dIscussIon
The morbidities selected to be measured in approximately 
3600 patients over 18 months starting October 2015 cover 
a range of phenomena associated with paediatric cardiac 
surgery, including indicators of organ damage such as 
acute kidney injury and necrotising enterocolitis, acute 
events such as cardiac arrest (included as a ‘major adverse 
event’), the necessity for major interventions in the intra-
operative period such as ECMO, and problems feeding 
that, while not necessarily a priority during the intraoper-
ative period, are considered to have a considerable impact 
on children and families in the months that follow.
At each stage of selection, the morbidity that was 
ranked of greatest importance by the panel was neurolog-
ical impairment. This came as little surprise to the study 
investigators and vindicates the inclusion in our overar-
ching programme of research of a parallel evaluation of 
the ‘Brief Developmental Assessment’, which it is hoped 
will provide a tool that can be deployed by nursing staff 
to identify patients who would benefit from referral to 
specialist neurological or other developmental services. 
Box 1 The final list of nine selected morbidities
 ► Acute neurological event.
 ► Unplanned reoperation/reintervention.
 ► Problems feeding (excluding necrotising enterocolitis).
 ► Need for renal replacement therapy (excluding extracorporeal 
membrane oxygenation).
 ► Major adverse event.
 ► Extracorporeal life support / extracorporeal membrane oxygenation. 
 ► Necrotising enterocolitis.
 ► Hospital acquired infection (graded/categorised).
 ► Prolonged pleural effusion/chylothorax.
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However, it is fair to say that inclusion on the panel of 
family representatives and clinicians from outside the 
tertiary surgical centres brought other issues such as 
problems feeding and poor communication between 
clinical teams and families to greater prominence than 
if the panel had consisted solely of tertiary clinicians or if 
the study investigators had chosen the morbidities them-
selves.
We found that opening up the process of choosing 
the metrics by which services should monitor their 
performance to include the perspectives of patients and 
family representatives, which is in line with policy initia-
tives in England,32 brought challenges. Throughout our 
work, there was a tension between choosing a ‘clean’ 
set of ‘clinical’ measures that most closely matched the 
understanding of ‘surgical morbidity’ among the tertiary 
clinicians on the panel and the inclusion of arguably 
murkier phenomena considered hugely important by 
families and those working in secondary care.
In particular, those working in surgical centres were 
more concerned than family representatives and others 
with the attribution of morbidity to the surgical act, 
keen to include morbidities that may be related in part 
to surgical technique (laryngeal nerve palsy and phrenic 
nerve injury) and degree of success (low cardiac output), 
and anxious to avoid the attribution to surgical teams of 
morbidities that are currently considered to ‘come with 
the territory’ of congenital heart disease and its surgical 
treatment. Family representatives and others highlighted 
the value of gathering information on the incidence and 
impact of key morbidities, even if they were not caused 
by surgery, not least as some of them may be reducible 
through interventions at other points in the care pathway.
sTrenGThs and lIMITaTIons
We consider that several features of our study design were 
key to drawing out and balancing these perspectives. 
The nominal group technique, starting as it does with 
an opportunity for each panellist to speak without inter-
ruption and within an embedded democratic process, 
is specifically designed to minimise the influence of 
perceived power differentials and dominant personalities 
within a group. This was reinforced by the use of a secret 
ballot process to determine group preferences, allowing 
panellists to record their disagreement with the positions 
stated by others without that being openly declared. The 
voting tool used distinguishes between unambiguous 
group preferences and those that rely on tie-breaking. 
This acceptance and presentation of lack of consensus 
helped to focus discussion on where it would be most 
valuable to the task of selecting a group of morbidities 
and divert unnecessary debate focused on achieving a 
false consensus through attrition.
Also, our choice to separate the process of identifying 
which morbidities are most important from the process 
of assessing the feasibility of defining and monitoring 
morbidities prevented all parties from self-censoring and 
clinical panellists from unconsciously using or claiming 
privileged knowledge of measurement processes to 
strengthen the case for morbidities they wanted to 
include.
Firm and expert chairing was essential to main-
taining this discipline. Having a Chair conversant with 
the clinical area but also experienced in working with 
multistakeholder groups including patient and family 
representatives was also key. Although it meant that the 
Chair brought their own clinical perspective to the table, 
the panel benefited from the Chair’s ability to discern 
between the wheat and chaff of clinical discussions and 
summarise for non-clinical participants. It is also ques-
tionable whether a Chair that was not an accomplished 
surgeon and clinical researcher would have held the 
respect of all parties through the process.
Separating the processes of judging the importance 
and the feasibility of routinely monitoring morbidities did 
however risk some of the subtlety of discussions slipping 
through the gaps between two panels of people. While 
the preparation of detailed summaries of panel meetings 
and the presence of the same facilitating team (CP and 
MU) at all meetings reduced this risk, we acknowledge 
that the defined morbidities that will be monitored do 
not correspond exactly in all cases to the phenomena 
deemed important by the selection panel.
Another limitation of the face-to-face approach 
adopted is that the panel was necessarily of limited size, 
and we cannot claim that the priorities and preferences 
expressed are representative of the respective profes-
sional groups and of families in general. For instance, the 
perspectives of families were represented by three indi-
viduals. That said, all three were aware of the concerns 
of the broader population of families through roles with 
a parent-led charity or from facilitating one of the focus 
groups that fed into the selection process.
In summary, we found that the inclusion of patient and 
family perspectives in identifying metrics for use in moni-
toring a highly specialised clinical service is a challenging 
but feasible exercise that can add valuable breadth to 
notions of quality and how to measure it.
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